Identification of patients with adenomas and serrated lesions
| Patients with | PCC group (n=496) | Control group (n=512) | Difference | p Value |
| n (%) | n (%) | |||
| ≥1 lesion | 349 (70.4) | 298 (58.2) | 12.2 | <0.001 |
| ≥1 serrated lesion | 229 (46.2) | 151 (29.5) | 16.7 | <0.001 |
| ≥1 adenoma | 233 (46.2) | 186 (36.3) | 9.8 | 0.002 |
| ≥1 adenoma ≥5 mm | 151 (30.4) | 119 (23.2) | 7.2 | 0.012 |
| ≥1 advanced neoplasia | 74 (14.9) | 57 (11.1) | 3.8 | 0.076 |
| ≥1 adenoma ≥10 mm | 64 (12.9) | 48 (9.4) | 3.5 | 0.092 |
| ≥1 carcinoma | 12 (2.4) | 12 (2.3) | 0.1 | 1.000 |
p Values were calculated using the Fisher exact test.
PCC, pancolonic chromoendoscopy.